Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus

BACKGROUND: Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. METHODS: Serological identification of antigens through recombinant cDNA ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Namiki, Toshiki, Takemoto, Minoru, Hayashi, Aiko, Yamagata, Hiroki, Ishikawa, Takahiro, Yokote, Koutaro, Li, Shu-Yang, Kubota, Masaaki, Zhang, Bo-Shi, Yoshida, Yoichi, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Kobayashi, Yoshio, Terada, Jiro, Naito, Akira, Tatsumi, Koichiro, Takizawa, Hirotaka, Nakamura, Rika, Kuroda, Hideyuki, Iwadate, Yasuo, Hiwasa, Takaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614393/
https://www.ncbi.nlm.nih.gov/pubmed/37904164
http://dx.doi.org/10.1186/s12902-023-01491-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614393/
https://www.ncbi.nlm.nih.gov/pubmed/37904164
http://dx.doi.org/10.1186/s12902-023-01491-3

Ejemplares similares